You are here

Article Text

Article menu
Commentary
Financing global health security: estimating the costs of pandemic preparedness in Global Fund eligible countries
  1. Stephanie Eaneff1,
  2. Matthew R Boyce1,
  3. Ellie Graeden1,
  4. David Lowrance2,
  5. Mackenzie Moore1,
  6. Rebecca Katz1
  1. 1 Center for Global Health Science and Security, Georgetown University, Washington, DC, USA
  2. 2 Global Fund to Fight AIDS, TB, and Malaria, Geneva, Switzerland
  1. Correspondence to Dr Rebecca Katz; Rebecca.Katz{at}georgetown.edu

https://doi.org/10.1136/bmjgh-2022-008960

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Summary box

    • The costs, globally, to build country-level public health capacity to address gaps in global health security over the next 5 years have been previously estimated as US$96–$204 billion, with an estimated US$63–131 billion in investment required over the next 3 years.

    • Research conducted prior to the COVID-19 pandemic indicated that over one-third of Global Fund’s budgets in 10 case study countries aligned with health security priorities articulated by the Joint External Evaluation, particularly in the areas of laboratory systems, antimicrobial resistance and workforce development.

    • We estimate that over 85% of investments needed to build country-level capacities in health security, globally, over the next 3 years are in countries eligible for Global Fund support.

    • Areas of investment opportunity aligned with the Global Fund’s core mandate include financing for surveillance and laboratory systems, combating antimicrobial resistance and developing and supporting robust healthcare and public health workforces.

    • In aggregate, global-level data highlight areas of opportunity for the Global Fund to expand and further develop its support of global health security in areas aligned with its mandate and programmatic scope.

    • Such investment opportunities have implications for existing budgeting and allocation processes and for implementation models, partners, programming and governance structures should these areas of potential expansion be prioritised.

    • This work emphasises a role for targeted, action-based cost estimation to identify gaps and to inform strategic investment decisions in global health.

    Introduction

    The COVID-19 pandemic demonstrated that the world was not well prepared to respond to an infectious disease threat of this magnitude. Countries across all socioeconomic and development categories have struggled to implement effective national responses. Substantial amounts of additional investment are required to support the development of country capacities to prevent, detect and respond to both existing and emerging infectious disease threats. Prior research efforts have estimated that between US$96 and $204 billion is required, globally, to advance country-level health …

    View Full Text

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.